Peptide antagonists of the vasopressin-2 receptor

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9631001
SERIAL NO

14427733

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to a new group of snake venom basic protease inhibitors having vasopressin-2 receptor antagonist activity that can be used in therapy, diagnosis, medical imaging, drug screening and research.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUEPARIS FRA
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)101 RUE DE TOLBIAC PARIS 75013
COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVESPARIS FRA PARIS PARIS
UNIVERSITE DE LIEGE4031 ANGLEUR
UNIVERSITY OF REGENSBURGUNIVERSITÄTSSTRASSE 31 REGENSBURG 93053

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Gilles, Nicolas Mitry-Mory, FR 3 0
Mendre, Christiane Argelliers, FR 1 0
Mouillac, Bernard Montpellier, FR 2 2
Quinton, Loïc Stree-Lez-Huy, BE 1 0
Reinfrank, Helen Kofering, DE 1 0
Servent, Denis Versailles, FR 5 3
Witzgall, Ralph Regensburg, DE 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Oct 25, 2024
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 25, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00